Financial News
Moderna’s COVID-19 vaccine defends against delta variant: study
August 13, 2021 at 10:20 AM EDT
Moderna’s COVID-19 vaccine resulted in antibody activity against variants, including the highly transmissible delta variant, six months following the second dose, a study found.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
